Index
Home
Site Layout
Context
The Trials
Editors' Dilemma
Medicine Control Agency
Ghostly Data
Academic Freedom
Academic Stalking


Context — PDAC

The Psychopharmacological Drugs Advisory Committee meetings that recommended the licensing of Prozac, and Zoloft, and then considered the issue of Prozac and suicide are listed here. These committee meetings dealt with issues of profound importance. In the case of both Prozac and Zoloft, it is clear that many committee members were troubled by the lack of convincing evidence for the efficacy of these drugs. In the case of the suicide issue, there was a clear calculus to be considered would more people die as a result of warnings than might die if Prozac was left without warnings about suicidality?

Click on file below for transcript. These are large PDF documents, so patience may be needed.